LIVN Earnings

LIVN reported its FY2025Q4 earnings on 2026-02-25, showcasing a revenue of 0.00 against an estimate of 351.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.67 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following LIVN's FY2025Q4 earnings announcement on 2026-02-25, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, LIVN's stock price tends to shift by an average of -1.64% in the 10 days leading up to earnings and +0.04% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate LIVN’s annual revenue to reach 354.00M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.78% and EPS estimates Revise Downward by -1.12% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between LIVN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.78%, while EPS estimates moved Revise Downward by -1.12% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LIVN's stock price typically moves by -1.64% in the 10 days before its earnings and +0.04% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.00 and revenue of 354.00M.

The earnings call presents a positive outlook with raised guidance for revenue growth, EPS, and free cash flow. The Q&A section highlights strategic investments in capacity expansion and new product launches, despite some conservative Q4 guidance. The positive feedback on the Essenz launch in China and the anticipated Medicare reimbursement increase for epilepsy therapy further support a positive sentiment. Although management avoided some specifics, the overall sentiment is positive, considering the strategic initiatives and growth prospects.